VK

V.Kadir Kadhiresan

Investor with J&J Innovation - JJDC Inc.,

Greater Boston

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Investments
Cross-functional Team Leadership
Biomedical Engineering
Product Launch
Start-ups
FDA
U.S. Food and Drug Administration (FDA)
Business Development
Business Strategy
Mergers & Acquisitions
Commercialization
Venture Capital
Biotechnology
Mergers
Clinical Research
Medical Devices
Healthcare
R&D

Education

Investments

HistoSonics

Convertible Note

Total Funding: $140M

Hyalex Orthopaedics

Series A

Total Funding: $33M

Spinal Modulation

Series C

Total Funding: $57M

Neotract

Series B

Total Funding: $28M

Work Experience

Johnson and Johnson Development Corporation

2013

  • Vice President, Venture Investments

    2013

    Create strategic growth options for Johnson & Johnson by investing in emerging health care businesses

New England Venture Capital Association

2024

  • BOD Member

    2024

The Wonderfund

2019

  • BOD Member

    2019

GI Windows

2020

  • BOD Member

    2020

HistoSonics, Inc.

2019

  • BOD Member

    2019

ON TARGET LABORATORIES

2017

  • BOD Member

    2017

Johnson and Johnson Development Corporation

2007 - 2013

  • Principal, Venture Investments

    2007 - 2013

    Create strategic growth options for Johnson & Johnson by investing in emerging health care businesses

Boston Scientific

2006 - 2007

  • Director, Business Development

    2006 - 2007

    Developed and executed on short and long-term corporate strategy via M&A, licensing,equity investments and strategic alliances

Guidant Corporation

2004 - 2006

  • Director, Research and Development

    2004 - 2006

    Led the development of clinical technologies for all three (Brady, Tachy, CHF) cardiac rhythm management product line